News Release

Obesity management pharmacotherapies and lifestyle treatment for pediatric obesity management

JAMA Pediatrics

Peer-Reviewed Publication

JAMA Network

About The Study: The findings of this systematic review and network meta-analysis suggest that combining lifestyle treatment with obesity management medications was associated with the greatest short-term (typically 6 to 12 months) weight reduction in adolescents with obesity. Health behavior and lifestyle treatment remained an indispensable component of any effective weight management, delivering meaningful weight loss and healthier body composition on its own. Combined with lifestyle treatment, pharmacotherapy was a key component, not solely an adjunct, associated with the greatest body mass index (BMI) and BMI score improvements, and long-term sustainability and safety were monitored.           

Corresponding Author: To contact the corresponding author, Bjorn T. Tam, PhD, email bjorntam@hkbu.edu.hk.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamapediatrics.2026.2248)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2026.2248?guestAccessKey=cbe93f86-f6f2-40da-87ce-c910b069a258&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062226


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.